M. D. Homoeo Lab Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 2.88 Cr
- Company Age 29 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.92 M
- Satisfied Charges ₹ 7.55 M
- Revenue Growth 9.35%
- Profit Growth -13.05%
- Ebitda 0.69%
- Net Worth 58.33%
- Total Assets 13.96%
About M. D. Homoeo Lab
M. D. Homoeo Lab Private Limited (MDHLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 02 June 1995 and has a history of 29 years and eight months. Its registered office is in Ghazipur, Uttar Pradesh, India.
The Corporate was formerly known as M. D. Homeo Lab Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 2.88 Cr.
The company currently has active open charges totaling ₹7.92 M. The company has closed loans amounting to ₹7.55 M, as per Ministry of Corporate Affairs (MCA) records.
Muni Singh, Vijendra Singh, Shalini Singh, and Two other members serve as directors at the Company.
Company Details
- Location
Ghazipur, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85193UP1995PTC018166
- Company No.
018166
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jun 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
What products or services does M. D. Homoeo Lab Private Limited offer?
M. D. Homoeo Lab Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Gastrointestinal Drugs, Fresh Flowers, Plants & Trees, Outdoor Plant, Homeopathic Drugs, Homoeopathic Syrup, Homoeopathic Drops, Veterinary Medicines, Homeopathic Veterinary Medicines, Arsenicum Album.
Who are the key members and board of directors at M. D. Homoeo Lab?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Muni Singh ![]() | Managing Director | 02-Jun-1995 | Current |
Board Members (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vijendra Singh ![]() | Director | 01-Jun-2016 | Current |
Shalini Singh ![]() | Director | 01-Jun-2016 | Current |
Jitendra Singh ![]() | Director | 01-Jun-2016 | Current |
Annapurna Singh ![]() | Director | 01-Jun-2016 | Current |
Financial Performance of M. D. Homoeo Lab.
M. D. Homoeo Lab Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 9.35% increase. The company also saw a substantial fall in profitability, with a 13.05% decrease in profit. The company's net worth Soared by an impressive increase of 58.33%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of M. D. Homoeo Lab?
In 2022, M. D. Homoeo Lab had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹0.79 Cr
₹0.76 Cr
Charges Breakdown by Lending Institutions
- Others : 0.79 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
15 Jul 2017 | Others | ₹0.42 M | Open |
28 Sep 2005 | Others | ₹7.50 M | Open |
30 Dec 2010 | Union Bank Of India | ₹1.50 M | Satisfied |
04 Dec 2008 | Union Bank Of India | ₹1.30 M | Satisfied |
03 Dec 2008 | Union Bank Of India | ₹0.80 M | Satisfied |
How Many Employees Work at M. D. Homoeo Lab?
M. D. Homoeo Lab has a workforce of 44 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of M. D. Homoeo Lab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped M. D. Homoeo Lab's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.